MedTrace Logo

LRRK2, GBA and Other Genetic Biomarkers in Eastern European (Ashkenazi) Jews With and Without Parkinson's Disease

NCT04668898 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 203

Last updated 2025-04-16

No results posted yet for this study

Summary

Single site observational study focused on elucidating the genes and biochemical pathways involved in causing Parkinson disease.

Conditions

  • Parkinson Disease
  • LRRK2
  • GBA Gene Mutation

Sponsors & Collaborators

Principal Investigators

  • Rachel Saunders-Pullman, MD, MPH · Icahn School of Medicine at Mount Sinai

  • Laurie Ozelius, PhD · Massachusetts General Hospital

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2025-04-01
Completion
2025-04-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04668898 on ClinicalTrials.gov